V-ATPase A2 inhibitors constitute a distinct chemical class of compounds designed to selectively target and inhibit the A2 isoform of V-ATPase (Vacuolar-type ATPase). V-ATPases are multi-subunit, membrane-bound enzyme complexes present in various eukaryotic cells and play a crucial role in regulating intracellular pH and ion homeostasis. Among the different isoforms, V-ATPase A2 is particularly important for cellular acidification processes, primarily within lysosomes and endosomes. The functional significance of V-ATPase A2 lies in its ability to pump protons across intracellular membranes, leading to acidification of luminal compartments. This process is essential for maintaining cellular homeostasis, as it facilitates protein degradation within lysosomes, receptor-mediated endocytosis, and the proper functioning of other acidic organelles. Dysregulation of V-ATPase A2 can have detrimental effects on various cellular processes, including vesicular trafficking, autophagy, and cellular responses to environmental stimuli.
V-ATPase A2 inhibitors are meticulously designed chemical entities, typically small molecules, that interfere with the enzymatic activity of V-ATPase A2. By selectively binding to specific regions of the enzyme complex, these inhibitors impede the pumping of protons across the membranes, consequently disrupting the acidification process. This disruption, in turn, can lead to altered cellular functions and signaling pathways that rely on intracellular pH control. Researchers and scientists have extensively studied V-ATPase A2 inhibitors to unravel the intricacies of V-ATPase function and explore their potential applications in various cellular processes and disease conditions. Research involving cell-based assays has shed light on the mechanisms of action of these inhibitors and their effects on cellular functions. Additionally, the development of structural information on V-ATPase A2 has been instrumental in the rational design and optimization of these inhibitors to enhance their specificity and potency.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
This is a well-known V-ATPase A2 inhibitor often used in research to study the roles of V-ATPase in cellular processes. It blocks the activity of V-ATPase, leading to impaired lysosomal acidification. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Another commonly used V-ATPase A2 inhibitor in research, Concanamycin A, interferes with the acidification of lysosomes, affecting various cellular functions. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Although primarily known as a proton pump inhibitor (PPI) used for acid-related gastrointestinal conditions, Omeprazole can also inhibit V-ATPase A2 activity in some contexts. | ||||||
Atpenin A5 | 119509-24-9 | sc-202475 sc-202475A sc-202475B sc-202475C | 250 µg 1 mg 10 mg 50 mg | $195.00 $540.00 $2905.00 $12885.00 | 17 | |
Derived from the fermentation broth of Aspergillus niger, Atpenin A5 is a potent V-ATPase A2 inhibitor that has been investigated for its anticancer properties. | ||||||
Tanshinone IIA | 568-72-9 | sc-200932 sc-200932A | 5 mg 25 mg | $88.00 $316.00 | 22 | |
A natural product found in the Salvia miltiorrhiza plant, Tanshinone IIA has shown V-ATPase A2 inhibitory effects. | ||||||
Gentamicin sulfate | 1405-41-0 | sc-203334 sc-203334A sc-203334F sc-203334B sc-203334C sc-203334D sc-203334E | 1 g 5 g 50 g 100 g 1 kg 2.5 kg 7.5 kg | $56.00 $179.00 $509.00 $725.00 $1836.00 $2652.00 $6248.00 | 3 | |
Gentamycin inhibits V-ATPase A2 activity, leading to altered lysosomal acidification in certain cell types. | ||||||